Loading...
XNSE
FDC
Market cap737mUSD
Nov 12, Last price  
407.20INR
Name

F D C Ltd

Chart & Performance

D1W1MN
XNSE:FDC chart
P/E
24.85
P/S
3.14
EPS
16.39
Div Yield, %
Shrs. gr., 5y
-1.14%
Rev. gr., 5y
9.53%
Revenues
21.08b
+8.94%
3,500,751,0004,314,724,0004,951,231,0005,891,307,0006,614,582,0007,076,094,0007,105,408,0007,700,309,0008,425,534,0008,867,123,00010,012,247,00010,089,576,00010,704,743,00010,848,904,00013,374,192,00013,268,276,00015,257,457,00017,837,502,00019,351,996,00021,081,204,000
Net income
2.67b
-12.59%
699,077,000656,139,000631,689,000862,093,0001,491,304,0001,508,903,0001,340,880,0001,551,705,0001,353,184,0001,481,454,0001,566,168,0001,885,320,0001,735,091,0001,697,888,0002,398,784,0003,013,456,0002,164,033,0001,940,374,0003,052,233,0002,667,881,000
CFO
3.64b
+64.95%
544,325,000648,431,000936,703,000881,193,0001,681,645,0001,213,538,0001,420,733,0001,499,403,0001,484,846,0001,197,957,0001,747,630,0001,533,223,0001,498,430,0001,124,288,0002,503,806,0002,070,815,0001,616,522,0001,549,131,0002,207,674,0003,641,577,000
Dividend
Mar 19, 20200.8 INR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.
IPO date
Aug 07, 1997
Employees
Domiciled in
IN
Incorporated in
IN

Valuation

Title
INR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT